Renu Meena

Renu Meena

Medical Content Writer

About Renu Meena

Renu Meena is a Medical Content Writer with a strong pharmacy-practice background and a B.Pharm from Rajasthan University of Health Sciences (RUHS), Jaipur. With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Qualification
Bachelor of Pharmacy (B.Pharm)
Experience
4+ years
Specialization
  • Medical & Pharmaceutical Content Writing (products + blogs + patient education)
  • Disease Education and disease management guide
  • Medication Use Content (how to use, safety, precautions, adherence support)
  • Drug Safety / Pharmacovigilance content
  • Regulatory-aligned writing, including familiarity with: ICH guidelines, GVP modules, ICD-10 and ICD-11, CIOMS working groups, Regulatory reporting obligations, Patient safety analysis activities
  • Content types: evidence-based articles, educational materials, compliance-friendly health content
Experience
  • Started career as a Pharmacist, building hands-on expertise in:

    • Medication management

    • Patient counselling

    • Practical pharmaceutical care workflows

  • Transitioned into Medical Writing / Disease Content / Medical Affairs, contributing to:

    • Product/medicine information content

    • Disease education and management guides

    • Drug safety and compliance-focused health content

  • Known for detail orientation, research strength, and staying updated with pharmacology and healthcare advancements

Articles by Renu Meena

Flibanserin Addyi : Breakthrough Treatment for Female Sexual Desire Disorder

In 2015, the U.S. Food and Drug Administration (FDA) made history by approving Flibanserin, the first treatment for female sexual dysfunction, specifically addressing hypoactive sexual desire disorder (HSDD) in premenopausal women. Marketed under the brand name Addyi. This medication provides an option for women experiencing distress due to low sexual...

Medicine Import Guidelines of Germany for Personal Use

The German Medicines Act (AMG) regulates the requirements for manufacturing, approving, dispensing, and importing medicines. Under certain circumstances, life-saving medications that are not approved or available in Germany for personal use can be imported for personal use. Legal FrameworkAccording to Section 73, Paragraph 2, of the AMG, the import of medicines...

Medicine Import Guidelines of Australia for Personal Use

If you need to import a medicine not approved in Australia, the Therapeutic Goods Administration (TGA) allows for personal importation under specific conditions. Here’s what you need to know to ensure a smooth and legal import process.What is the Personal Importation Scheme?The TGA’s Personal Importation Scheme permits individuals to import therapeutic goods for personal...